Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05170126 · ClinicalTrials.gov registry record

A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring

A clinical trial of Multiple Sclerosis, sponsored by Bristol-Myers Squibb.

Recruiting
Registry status
1,182
Enrollment target
3
Study locations

NCT05170126 is a study of Multiple Sclerosis that is actively recruiting participants, run by Bristol-Myers Squibb. The registered enrollment target is 1,182 participants, above the 581-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (103% higher). The trial reports 3 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05170126, a study of Multiple Sclerosis, is actively recruiting participants, sponsored by Bristol-Myers Squibb.

RECRUITING
Registry status
1,182 participants
Enrollment target
3
Study locations

Study Summary

The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.

Conditions Studied

Multiple Sclerosis

Study Locations (3)

Maryland

  • Evidera INC. - Bethesda
  • Evidera - Bethesda

Other

  • Marienhospital Herne, Klinikum Der Ruhr-Universitaet Bochum - Herne

Trial Details

FieldValue
Enrollment Target 1,182 participants
Start Date 2022-07-15
Est. Completion 2032-06-30

Sponsor

Bristol-Myers Squibb

1,025 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT05170126

The ClinicalTrials.gov registry entry for NCT05170126 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,182 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 581-participant average among 315 other Multiple Sclerosis trials with a reported enrollment target (103% higher). The listed sponsor is Bristol-Myers Squibb, which has 1,025 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Multiple Sclerosis appearing as the primary indexed condition, and to 0 interventions.

NCT05170126 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Maryland, Other.

Frequently Asked Questions

What is clinical trial NCT05170126 about?

NCT05170126 is a clinical study titled "A Study on the Safety of Ozanimod Exposure in Pregnant Women and Their Offspring". The purpose of this study is to provide information on maternal, fetal, and infant outcomes following exposure of ozanimod during pregnancy so that participants and physicians can weigh the benefits and risks of exposure to the pharmaceutical during pregnancy and make informed treatment decisions.

What is the current status of trial NCT05170126?

This trial is currently recruiting. The enrollment target is 1,182 participants. The study started on 2022-07-15. Estimated completion is 2032-06-30.

What conditions does trial NCT05170126 study?

This clinical trial studies the following conditions: Multiple Sclerosis.

Who is sponsoring clinical trial NCT05170126?

This trial is sponsored by Bristol-Myers Squibb, which has 1,025 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05170126 being conducted?

This trial has 3 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Multiple Sclerosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Multiple Sclerosis

All registered trials for this condition

Maryland

All trials with a study site in Maryland

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.